MedPath

Comparative Study of Metformin Versus Doxycycline in Moderate to Severe Adult Acne Vulgaris Patients.

Phase 2
Recruiting
Conditions
Acne Vulgaris
Interventions
Registration Number
NCT06252194
Lead Sponsor
Bangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh
Brief Summary

The goal of this clinical trial is to compare the effect of doxycycline and metformin in treatment of acne vulgaris patients. The main question is aimed to answer is whether metformin is more effective than doxycycline in treatment of acne vulgaris patient or not.

Patients will be asked to take doxycycline along with tropical treatment in one group and metformin along with tropical treatment in another group.

Researcher will compare the clinical improvement in two groups.

Detailed Description

Not available

Recruitment & Eligibility

Status
RECRUITING
Sex
All
Target Recruitment
120
Inclusion Criteria

Newly diagnosed moderate and severe AV patients diagnosed by a dermatologist

Exclusion Criteria
  • Patients receiving topical retinoids within last two months
  • Pregnancy and lactation
  • History of corticosteroids intake
  • Suffering from malignancy or any cosmetic induced acne

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Group AMetformin and doxycyclineMetformin 500 mg twice daily along with topical retinoids for 12 weeks
Group BMetformin and doxycyclineDoxycycline 100 mg twice daily along with topical retinoids for 12 weeks
Primary Outcome Measures
NameTimeMethod
Global Acne Grading System (GAGS) Score12 weeks

Acne Vulgaris Severity assesment by GAGS score

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

BSMMU

🇧🇩

Dhaka, Bangladesh

© Copyright 2025. All Rights Reserved by MedPath